 Connection
Jacob Painter to Analgesics, Opioid
This is a "connection" page, showing publications Jacob Painter has written about Analgesics, Opioid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.522 |
|
|
|
-
Dayer LE, Peng C, Williams AJ, Luciani L, Lowery J, Butterfield B, Painter JT. Factors Contributing to Opioid Overprescribing at Surgical Discharge. J Surg Res. 2025 Feb; 306:224-229.
Score: 0.643
-
Cetto AV, Chandler MW, Shah NK, Luciani LL, Painter J. Evaluating the Impact of Buprenorphine on Depressive Symptoms Among Veterans with Chronic Pain. J Pain Palliat Care Pharmacother. 2025 Mar; 39(1):58-63.
Score: 0.637
-
Painter JT, McLeroy-Charles K, Moore H, Harrington S, Dayer LE. Outpatient Patient Controlled Analgesia (PCA) for the Palliative Care Patient. J Pain Palliat Care Pharmacother. 2024 Dec; 38(4):367-372.
Score: 0.624
-
Painter JT, Peng C, Burlette M, Clement C, Luciani L, Azhar G, Dayer L. The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults. J Pain Palliat Care Pharmacother. 2024 Dec; 38(4):327-333.
Score: 0.617
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2024 Jun; 18(3):917-927.
Score: 0.563
-
Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602.
Score: 0.446
-
Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 03; 159(3):451-459.
Score: 0.400
-
Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. J Opioid Manag. 2017 Mar/Apr; 13(2):95-103.
Score: 0.373
-
Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol. 2013 Mar; 19(2):72-7.
Score: 0.283
-
Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clin Ther. 2013 Mar; 35(3):303-11.
Score: 0.282
-
Becker WC, Seal KH, Nelson DB, DeRonne BM, Kats AM, Morasco BJ, Frank JW, Makris UE, Painter JT, Allen KD, Mixon AS, Bohnert A, Reznik TE, Hagedorn HJ, Hammett P, Borsari B, Baxley C, Krebs EE. Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial. JAMA Intern Med. 2025 Apr 01; 185(4):372-381.
Score: 0.163
-
Krebs EE, Becker WC, Nelson DB, DeRonne BM, Jensen AC, Kats AM, Morasco BJ, Frank JW, Makris UE, Allen KD, Naylor JC, Mixon AS, Bohnert A, Reznik TE, Painter JT, Hudson TJ, Hagedorn HJ, Manuel JK, Borsari B, Purcell N, Hammett P, Amundson EC, Kerns RD, Barbosa MR, Garvey C, Jones EJ, Noh MY, Okere JB, Bhushan S, Pinsonnault J, Williams BE, Herbst E, Lagisetty P, Librodo S, Mapara PS, Son E, Tat C, Marraffa RA, Seys RL, Baxley C, Seal KH. Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy: The VOICE Randomized Clinical Trial. JAMA Intern Med. 2025 Feb 01; 185(2):208-220.
Score: 0.161
-
Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227.
Score: 0.139
-
Chopra D, Li C, Painter JT, Bona JP, Nookaew I, Martin BC. Characteristics and Network Influence of Providers Involved in the Treatment of Patients With Chronic Back, Neck or Joint Pain in Arkansas. J Pain. 2021 12; 22(12):1681-1695.
Score: 0.126
-
Muzzio K, Chandler M, Painter JT, Dragic L. Characterizing Patients after Opioid Taper in a VA Medical Center. J Pain Palliat Care Pharmacother. 2021 Jun; 35(2):84-90.
Score: 0.125
-
Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247.
Score: 0.113
-
Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339.
Score: 0.106
-
Midboe AM, Martino S, Krein SL, Frank JW, Painter JT, Chandler M, Schroeder A, Fenton BT, Troszak L, Erhardt T, Kerns RD, Becker WC. Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol. Implement Sci. 2018 11 29; 13(1):145.
Score: 0.105
-
Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain Med. 2018 04 01; 19(4):774-787.
Score: 0.100
-
Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S. Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. Addict Behav. 2018 11; 86:138-145.
Score: 0.100
-
Gressler LE, Hammond DA, Painter JT. Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. J Pain Palliat Care Pharmacother. 2017 Sep - Dec; 31(3-4):228-236.
Score: 0.099
-
Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 06; 158(6):1039-1045.
Score: 0.095
-
Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Am J Health Syst Pharm. 2014 Sep 15; 71(18):1539-54.
Score: 0.079
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186.
Score: 0.038
-
Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023 Sep; 37(3):234-245.
Score: 0.036
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 03 01; 39(3):107-118.
Score: 0.035
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957.
Score: 0.034
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|